Blume Capital Management’s Merck MRK Stock Holding History

Blume Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$180K	Hold	1,400	–	–	0.03%	127
2026 Q1	$168K	Sell	1,400 -250	-15%	-$28.9K	0.03%	123
2025 Q4	$174K	Sell	1,650 -8,254	-83%	-$775K	0.03%	120
2025 Q3	$831K	Buy	9,904 +7,574	+325%	+$624K	0.16%	72
2025 Q2	$184K	Buy	2,330 +30	+1%	+$2.38K	0.04%	118
2025 Q1	$206K	Hold	2,300	–	–	0.05%	110
2024 Q4	$229K	Hold	2,300	–	–	0.05%	102
2024 Q3	$261K	Hold	2,300	–	–	0.06%	92
2024 Q2	$285K	Hold	2,300	–	–	0.07%	89
2024 Q1	$303K	Sell	2,300 -100	-4%	-$12.3K	0.07%	84
2023 Q4	$262K	Hold	2,400	–	–	0.07%	83
2023 Q3	$247K	Sell	2,400 -100	-4%	-$10.8K	0.07%	83
2023 Q2	$288K	Hold	2,500	–	–	0.08%	80
2023 Q1	$266K	Sell	2,500 -200	-7%	-$21.6K	0.08%	77
2022 Q4	$300K	Sell	2,700 -200	-7%	-$20.4K	0.1%	77
2022 Q3	$250K	Sell	2,900 -172	-6%	-$15.4K	0.09%	73
2022 Q2	$280K	Buy	3,072 +734	+31%	+$65.1K	0.11%	69
2022 Q1	$192K	Buy	2,338 +238	+11%	+$18.8K	0.06%	85
2021 Q4	$161K	Hold	2,100	–	–	0.05%	104
2021 Q3	$158K	Hold	2,100	–	–	0.06%	101
2021 Q2	$163K	Sell	2,100 -318	-13%	-$23.7K	0.06%	93
2021 Q1	$178K	Buy	2,418 +951	+65%	+$70.2K	0.07%	86
2020 Q4	$115K	Hold	1,467	–	–	0.05%	89
2020 Q3	$116K	Hold	1,467	–	–	0.06%	86
2020 Q2	$108K	Hold	1,467	–	–	0.06%	86
2020 Q1	$107K	Hold	1,467	–	–	0.07%	78
2019 Q4	$127K	Hold	1,467	–	–	0.06%	86
2019 Q3	$117K	Hold	1,467	–	–	0.06%	88
2019 Q2	$117K	Hold	1,467	–	–	0.06%	86
2019 Q1	$116K	Hold	1,467	–	–	0.06%	89
2018 Q4	$107K	Hold	1,467	–	–	0.06%	90
2018 Q3	$99K	Hold	1,467	–	–	0.05%	85
2018 Q2	$85K	Hold	1,467	–	–	0.05%	85
2018 Q1	$76K	Hold	1,467	–	–	0.04%	93
2017 Q4	$79K	Sell	1,467 -220	-13%	-$12.2K	0.04%	98
2017 Q3	$103K	Hold	1,687	–	–	0.05%	82
2017 Q2	$103K	Sell	1,687 -105	-6%	-$6.39K	0.06%	72
2017 Q1	$109K	Hold	1,792	–	–	0.06%	69
2016 Q4	$101K	Hold	1,792	–	–	0.06%	69
2016 Q3	$107K	Buy	1,792 +220	+14%	+$12.9K	0.07%	66
2016 Q2	$86K	Hold	1,572	–	–	0.06%	74
2016 Q1	$79K	Hold	1,572	–	–	0.05%	77
2015 Q4	$79K	Hold	1,572	–	–	0.06%	82
2015 Q3	$74K	Hold	1,572	–	–	0.06%	75
2015 Q2	$85K	Sell	1,572 -2,829	-64%	-$159K	0.06%	76
2015 Q1	$241K	Sell	4,401 -290	-6%	-$16.4K	0.17%	47
2014 Q4	$254K	Buy	+4,691	New	+$261K	0.18%	50
2014 Q1	–	Sell	-15,028	Closed	-$718K	–	251
2013 Q4	$718K	Buy	+15,028	New	+$687K	0.59%	32

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Blume Capital Management's MRK Position: Q2 2026 in Review

Blume Capital Management held its Merck (MRK) position steady in Q2 2026 at 1,400 shares worth $180K. The position accounts for 0.03% of the portfolio, ranked #127.

Blume Capital Management first reported a position in MRK in Q4 2013 and has held it in 48 quarters since. The position peaked at $831K in Q3 2025. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Blume Capital Management held 1,400 shares of Merck worth $180K as of Q2 2026.
Blume Capital Management left its Merck share count unchanged in Q2 2026.
Merck made up 0.03% of Blume Capital Management's portfolio in Q2 2026, its #127 holding.
Blume Capital Management first reported a position in Merck in Q4 2013 and has held it in 48 quarters since.
Blume Capital Management's Merck position peaked at $831K in Q3 2025.
1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.